No Prescription |
 |
 | ||
|
TOBA Tobrex |
|
| ||
No Prescription » Prescription Drugs 16 » TOBA Tobrex Tobramycin kills bacteria that cause certain eye infections.Tobramycin comes as eyedrops and eye ointment. The eye drops usually are applied every 4-8 hours; the ointment usually is applied two to four times a day. Follow the directions on your prescription label carefully and ask your doctor or pharmacist to explain any part you do not understand. Use tobramycin exactly as directed. Do not use more or less of it or use it more often than prescribed by your doctor.To use the eyedrops follow these instructions: Wash your hands thoroughly with soap and water. Use a mirror or have someone else put the drops in your eye. Remove the protective cap. Make sure that the end of the dropper is not chipped cracked. Avoid touching the dropper tip against your eye or anything else. Hold the dropper tip down at all times to prevent drops from flowing back into the bottle and contaminating the remaining contents. Lie down or tilt your head back. Holding the bottle between your thumb and index finger place the dropper tip as near as possible to your eyelid without touching it. Brace the remaining fingers of that hand against your cheek or nose. With the index finger of your other hand pull the lower lid of the eye down to form a pocket. Drop the prescribed number of drops into the pocket made by the lower lid and the eye. Placing drops on the surface of the eyeball can cause stinging. Close your eye and press lightly against the lower lid with your finger for 2-3 minutes to keep the medication in the eye. Do not blink. Replace and tighten the cap right away. Do not wipe or rinse it off. Wipe off any excess liquid from your cheek with a clean tissue. Wash your hands again. Buy TOBA Tobrex and other Prescription Drugs 16 products online at Medstore. Buy Online at Medstore - Click Here!
About TOBA Tobrex: Product Type: Prescription Drugs 16 TOBA ( Tobrex GENERIC Tobramycin ) TOBA (Tobrex GENERIC Tobramycin) Tobrex GENERIC Tobramycin 0.30% Tobrex GENERIC Tobramycin TOBA
View more Prescription Drugs 16 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
